Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06795113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2013
Completion date
December 31, 2029
Enrollment
4,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma